BioPlus Acquisition Corp.

BIOS | NASDAQ

Price Alert Chart Builder DCF Calculator

$10.79

-$0.01 (-0.09%)

Oct 06, 2023, 03:46 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $209.07M

Enterprise Value $75.89M

Beta 0.00

Average Volume N/A

Shares Outstanding (Diluted) 24.48M

Shares Change YoY -16.47%

Institutional Ownership N/A

Exchange N/A

ISIN N/A

Price Performance

Price Change 1M N/A

Price Change 3M N/A

Price Change 6M N/A

Price Change YTD N/A

Price Change 1Y N/A

Price Change 3Y N/A

Price Change 5Y N/A

1M CAGR (ann.) 0.3%

1Y CAGR (ann.) 7.5%

5Y CAGR (ann.) N/A

All-Time CAGR 5.9%

Valuation

PE Ratio 35.97

Forward PE N/A

PEG Ratio 0.00

Forward PEG 0.00

PS Ratio N/A

Forward PS N/A

PB Ratio 1.72

P/FCF Ratio -129.65

P/Adj. FCF Ratio -129.65

P/OCF Ratio -359.67

EV/Sales N/A

EV/EBIT -61.95

EV/EBITDA -35.10

EV/FCF -47.06

Earnings Yield 2.8%

FCF Yield -0.8%

Adj. FCF Yield -0.8%

Financial Health

Net Cash $133.19M

Total Debt $5.25M

Cash & Short-Term Investments $2.45K

Total Assets $138.63M

Current Ratio 1.04

Quick Ratio 1.04

Debt / Equity Ratio 0.02

Debt / EBITDA -2.43

Debt / FCF -3.26

OCF / Debt -0.31

Interest Coverage 0.00

Altman Z-Score 7.28

Piotroski F-Score 2

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) N/A

Returns

Return on Assets 2.2%

Return on Equity 2.3%

Return on Invested Capital -0.5%

Return on Capital Employed -0.5%

Return on Tangible Assets 2.2%

Historical Growth (CAGR)

Revenue CAGR 3Y -150.0%

Revenue CAGR 5Y -75.8%

Revenue CAGR 10Y -7.1%

EPS CAGR 3Y 161.9%

EPS CAGR 5Y 170.1%

EPS CAGR 10Y 19.4%

FCF CAGR 3Y -128.2%

FCF CAGR 5Y 21.5%

FCF CAGR 10Y 35.0%

Analyst Forecasts

Analyst Rating Hold

Analyst Count 0

EPS Growth Next 3Y N/A

Revenue Growth Next 3Y N/A

Earnings Date Jun 29, 2023

EPS Estimate (next Q) N/A

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number $7.55

Graham Upside -30.0%

Lynch Fair Value $7.50

Lynch Upside -30.5%

Price Target N/A

Price Target Upside N/A

Cash Flow

Operating Cash Flow $-1.61M

Free Cash Flow $-1.61M

Adj. Free Cash Flow $-1.61M

FCF Per Share -$0.03

OCF Per Share -$0.03

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-1.17M

Operating Income $-2.16M

EBITDA $-2.16M

Net Income $5.8M

EPS (Diluted) $0.30

Revenue / Employee N/A

Profit / Employee N/A

Employees N/A